RIO DE JANEIRO, BRAZIL - The National Health Regulator (Anvisa) received, on Monday (19), a request for emergency use of the drug Sotrovimab, a monoclonal antibody developed for the treatment of covid-19. The request was submitted by the laboratory Glaxo Smith Kline.
https://www.youtube.com/watch?v=Xz8VgVlkZQs&ab channel=KhaleejTimes
The deadline for analyzing the request is 30 days, counting from the confirmation that all the necessary documents have been delivered.
According to Anvisa, the drug has not had clinical studies conducted in Brazil so far.
UAE FINDS DRUG IS 100% SUCCESSFUL AT PREVENTING DEATHS
Between 30 June . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here
The Rise And Rise Of The Pharma Industry In Ireland todayfm.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from todayfm.com Daily Mail and Mail on Sunday newspapers.
Subscription Notification
We have noticed that there is an issue with your subscription billing details. Please update your billing details here
Please update your billing information
The subscription details associated with this account need to be updated. Please update your billing details here to continue enjoying your subscription.
Your subscription will end shortly
Please update your billing details here to continue enjoying your access to the most informative and considered journalism in the UK.
كورونا تحالف جديد لتطوير لقاحات ضد | جريدة الأنباء alanba.com.kw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alanba.com.kw Daily Mail and Mail on Sunday newspapers.